Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-22-005596

Options or other derivatives

  • Chief Financial Officer acquired 135,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Bellemin Jean-Marc Chief Financial Officer 2022-01-14 Grant or award · Stock Option (right to buy) +135,000 135,000 D
Loading xslF345X03/tm223806-1_4seq1.xml…